1. Home
  2. Labeler Index
  3. Alembic Labs Llc
  4. 15955-305
  5. NDC Package Code: 15955-305-01 Glycopyrrolate

NDC Package 15955-305-01 Glycopyrrolate

Tablet Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
15955-305-01
Package Description:
100 TABLET in 1 BOTTLE, PLASTIC
Product Code:
15955-305
Proprietary Name:
Glycopyrrolate
Non-Proprietary Name:
Glycopyrrolate
Substance Name:
Glycopyrrolate
Usage Information:
Glycopyrrolate is used with other drugs to treat a certain type of stomach/intestinal ulcer (peptic ulcer). This medication may help relieve stomach/abdominal pain. However, it has not been shown to be effective in healing these ulcers, preventing them from returning, or preventing other problems caused by ulcers. Glycopyrrolate works by decreasing the amount of acid in the stomach. It also slows the natural movements of the gut and relaxes the muscles in the stomach/intestines. Glycopyrrolate belongs to a class of drugs known as anticholinergics.
11-Digit NDC Billing Format:
15955030501
NDC to RxNorm Crosswalk:
  • RxCUI: 197738 - glycopyrrolate 1 MG Oral Tablet
  • RxCUI: 197739 - glycopyrrolate 2 MG Oral Tablet
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Alembic Labs Llc
    Dosage Form:
    Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
    • Active Ingredient(s):
  • GLYCOPYRROLATE 1 mg/1
    • Pharmacologic Class(es):
  • Anticholinergic - [EPC] (Established Pharmacologic Class)
  • Cholinergic Antagonists - [MoA] (Mechanism of Action)
    • Sample Package:
    No
    FDA Application Number:
    ANDA203657
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    10-19-2012
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 15955-305-01?

    The NDC Packaged Code 15955-305-01 is assigned to a package of 100 tablet in 1 bottle, plastic of Glycopyrrolate, a human prescription drug labeled by Alembic Labs Llc. The product's dosage form is tablet and is administered via oral form.

    Is NDC 15955-305 included in the NDC Directory?

    Yes, Glycopyrrolate with product code 15955-305 is active and included in the NDC Directory. The product was first marketed by Alembic Labs Llc on October 19, 2012 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 15955-305-01?

    The 11-digit format is 15955030501. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-215955-305-015-4-215955-0305-01